Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2005-09-13
2005-09-13
Marschel, Ardin H. (Department: 1631)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C435S320100, C435S325000
Reexamination Certificate
active
06943240
ABSTRACT:
The invention pertains to murine TLR9 and related TLR9s which include murine-specific amino acids, as well as nucleic acids which encode those polypeptides. The present invention also includes fragments and biologically functional variants of the murine TLR9. The invention further relates to methods of using such murine and non-murine TLR9 nucleic acids and polypeptides, especially in methods for screening for agonists and antagonists of immunostimulatory CpG nucleic acids. Also included are murine TLR9 inhibitors which inhibit murine TLR9 activity by inhibiting the expression or function of murine TLR9. In a further aspect the present invention pertains to murine TLR7 and murine TLR8, as well as related TLR7 and TLR8 molecules which include murine-specific amino acids, as well as nucleic acids which encode those polypeptides. The present invention also includes fragments and biologically functional variants of the murine TLR7 and TLR8. Methods are included for screening for ligands of TLR7 and TLR8, as well as for inhibitors and agonists and antagonists of signaling mediated by TLR7 and TLR8.
REFERENCES:
patent: 5567604 (1996-10-01), Rando et al.
patent: 5663153 (1997-09-01), Hutcherson et al.
patent: 5723335 (1998-03-01), Hutcherson et al.
patent: 6013639 (2000-01-01), Peyman et al.
patent: 6121434 (2000-09-01), Peyman et al.
patent: 6194388 (2001-02-01), Krieg et al.
patent: 6207646 (2001-03-01), Krieg et al.
patent: 6214806 (2001-04-01), Krieg et al.
patent: 6218371 (2001-04-01), Krieg et al.
patent: 6239116 (2001-05-01), Krieg et al.
patent: 2002/0164341 (2002-11-01), Davis et al.
patent: 2002/0165178 (2002-11-01), Schetter et al.
patent: 2003/0050268 (2003-03-01), Krieg et al
patent: 2003/0055014 (2003-03-01), Bratzler
patent: 2003/0091599 (2003-05-01), Davis et al.
patent: 2003/0100527 (2003-05-01), Krieg et al.
patent: 2003/0104523 (2003-06-01), Lipford et al.
patent: 2003/0139364 (2003-07-01), Krieg et al.
patent: 2003/0148316 (2003-08-01), Lipford et al.
patent: 2003/0148976 (2003-08-01), Krieg et al.
patent: 2003/0166001 (2003-09-01), Lipford
patent: 2003/0181406 (2003-09-01), Schetter et al.
patent: 2003/0191079 (2003-10-01), Krieg et al.
patent: 1142472 (2001-10-01), None
patent: WO94/29469 (1994-12-01), None
patent: WO96/2555 (1996-02-01), None
patent: WO96/24380 (1996-08-01), None
patent: WO97/00957 (1997-01-01), None
patent: WO98/18810 (1998-05-01), None
patent: WO98/29430 (1998-07-01), None
patent: WO98/32462 (1998-07-01), None
patent: WO98/37919 (1998-09-01), None
patent: WO98/40100 (1998-09-01), None
patent: WO98/50547 (1998-11-01), None
patent: WO98/52581 (1998-11-01), None
patent: WO99/20756 (1999-04-01), None
patent: WO99/51259 (1999-10-01), None
patent: WO99/56755 (1999-11-01), None
patent: WO99/58118 (1999-11-01), None
patent: WO99/61056 (1999-12-01), None
patent: WO00/06588 (2000-02-01), None
patent: WO00/14217 (2000-03-01), None
patent: WO00/67023 (2000-11-01), None
patent: WO01/22972 (2001-04-01), None
patent: WO01/22990 (2001-04-01), None
patent: WO01/32877 (2001-05-01), None
patent: WO01/55386 (2001-08-01), None
patent: WO 02/069369 (2002-09-01), None
patent: WO 03/035695 (2003-01-01), None
patent: WO 03/043572 (2003-05-01), None
AF245704, Genbank, Jun. 21, 2000.
BE412777, Genbank, Jul. 24, 2000.
BE705670, Genbank, Sep. 12, 2000.
AQ984126, Genbank, Jan. 30, 2000.
AL356815, Genbank, May 25, 2000.
Aderem A et al., Toll-like receptors in the induction of the innate immune response.Nature.2000 Aug. 17;406(6797):782-7.
Agrawal A et al., Transposition mediated by RAG1 and RAG2 and its implications for the evolution of the immune system.Nature.Aug. 20 1998;394(6695):744-51.
Bauer S et al., Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition.Proc Natl Acad Sci USA.Jul. 31, 2001;98(16):9237-42.
Chaudhary PM et al., Cloning and characterization of two Toll/Interleukin-1 receptor-like genes TIL3 and TIL4: evidence for a multi-gene receptor family in humans.Blood.Jun. 1, 1998;91(11):4020-7.
Chuang TH et al., Cloning and characterization of a sub-family of human toll-like receptors: hTLR7, hTLR8 and hTLR9.Eur Cytokine Netw.Sep. 2000;11(3):372-8.
Demoulin JB et al., A single tyrosine of the interleukin-9 (IL-9) receptor is required for STAT activation, antiapoptotic activity, and growth regulation by IL-9.Mol Cell Biol.Sep. 1996;16(9):4710-6.
Du X et al., Three novel mammalian toll-like receptors: gene structure, expression, and evolution.Eur Cytokine Netw.Sep. 2000;11(3):362-71.
Eden CS et al., Host resistance to mucosal gram-negative infection. Susceptibility of lipopolysaccharide nonresponder mice.J Immunol.May 1, 1998;140(9):3180-5.
Feardon DT et al, The instructive role of innate immunity in the acquired immune response.Science.Apr. 5, 1996;272(5258):50-3.
Fujita N et al., Mechanism of transcriptional regulation by methyl-CpG binding Protein MBD1,Mol Cell Biol.20:5107-18 (2000).
Hacker H et al., Cell type-specific activation of mitogen-activated protein kinases by CpG-DNA controls interleukin-12 release from antigen-presenting cells.EMBO J.Dec. 15, 1999;18(24):6973-82.
Hacker H et al, CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation.EMBO J.Nov. 2, 1998;17(21):6230-40.
Hacker H et al., Immune cell activation by bacterial CpG-DNA through myeloid differentiation marker 88 and tumor necrosis factor receptor-associated factor (TRAF)6.J Exp Med.Aug. 21, 2000;192(4):595-600.
Hemmi H et al., A Toll-like receptor recognizes bacterial DNA.Nature.Dec. 7, 2000;408(6813):740-5.
Hoffmann JA et al., Phylogenetic perspectives in innate immunity.Science.May 21, 1999; 284(5418):1313-8.
Janeway CA Jr., Approaching the asymptote? Evolution and revolution in immunology.Cold Spring Harb Symp Quant Biol.1989;54 Pt 1:1-13.
Kirschning CJ et al., Human toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide.J Exp Med.Dec. 7, 1998;188(11):2091-7.
Krieg AM et al., Causing a commotion in the blood: immunotherapy progresses from bacteria to bacterial DNA,Immunol Today.Oct. 2000;21(10):521-6.
Krieg AM et al., CpG motifs in bacterial DNA trigger direct B-cell activation.Nature.Apr. 6, 1995;374(6522):546-9.
Liang H et al., Activation of human B cells by phosphorothioate oligodeoxynucleotides.J Clin Invest.Sep. 1, 1996;98(5):1119-29.
MacFarlane DE et al., Antagonism of immunostimulatory CpG-oligodeoxynucleotides by quinacrine, chloroquine, and structurally related compounds.J Immunol.Feb. 1, 1998;160(3):1122-31.
Manzel L et al., Lack of immune stimulation by immobilized CpG-oligodeoxynucleotide.Antisense Nucleic Acid Drug Dev.Oct. 1999;9(5):459-64.
Means TK et al., Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis.J Immunol.Oct. 1, 1999;163(7):3920-7.
Medzhitov R et al., A human homologue of the Drosophila Toll protein signals activation of adaptive immunity.Nature.Jul. 24, 1997;388(6640):394-7.
Medzhitov R et al., Innate immunity: the virtues of a nonclonal system of recognition.Cell.Oct. 31, 1997;91(3):295-8.
Muzio M et al., The human toll signaling pathway: divergence of nuclear factor kappaB and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6).J Exp Med.Jun. 15, 1998;187(12):2097-101.
Muzio M et al., Toll-like receptors; a growing family of immune receptors that are differentially expressed and regulated by different leukocytes.J Leukoc Biol.Apr. 2000;67(4):450-6.
Ohki et al., Solution structure of the methyl-CpG-binding domain of the methylation-dependent transcriptional repressor MBD1.EMBO J.Dec. 1, 1999;18(23):6653-61.
Poltorak A et al., Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.Science.Dec. 11, 1998;282(5396):2085-8.
Qureshi ST et al., Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4)J Exp Med.Feb. 15, 1999;189(4):615-25.
Rock FL et al., A family of human receptors structurally related to Drosophila Toll.Proc Natl Acad Sci USA.Jan. 20, 1998;95(2):588-93.
Stratford-Perricaudet LD et
Bauer Stefan
Lipford Grayson
Wagner Hermann
Coley Pharmaceuticals GmbH
Marschel Ardin H.
Smith Carolyn L.
Wolf Greenfield & Sacks P.C.
LandOfFree
Nucleic acids for high throughput screening of CpG-based... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nucleic acids for high throughput screening of CpG-based..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleic acids for high throughput screening of CpG-based... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3431848